David Oscier, MD

Univeristy Hospitals Dorset, United Kingdom

Poster(s):

• 1101 - An immuno-(epi)genomic classification of chronic lymphocytic leukemia refines outcome prediction

• 1121 - High-risk molecular features eclipse genomic complexity in predicting CLL patient outcomes; Insights from the UK CLL4, ARCTIC and ADMIRE trials.